Literature DB >> 742877

Penetration of amoxicillin into cerebrospinal fluid.

L J Strausbaugh, N I Girgis, I A Mikhail, D C Edman, W F Miner, M W Yassin.   

Abstract

The penetration of amoxicillin into cerebrospinal fluid (CFS) in the presence of meningeal inflammation was evaluated in patients with tuberculous meningitis. Serum and CSF concentrations of amoxicillin were measured at 2 h in nine patients who received a 1-g oral dose and at 1.5 and 4 h in ten patients who received a 2-g intravenous injection of sodium amoxicillin. After the oral dose, CSF concentrations ranged from 0.1 to 1.5 mug/ml. After the intravenous injection, CSF concentrations ranged from 2.9 to 40.0 mug/ml at 1.5 h and from 2.6 to 27.0 mug/ml at 4 h. These data on penetration suggest that parenterally administered sodium amoxicillin may be of value in the therapy of acute bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 742877      PMCID: PMC352576          DOI: 10.1128/AAC.14.6.899

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

Authors:  M H LEPPER; H F DOWLING
Journal:  AMA Arch Intern Med       Date:  1951-10

2.  Laboratory evaluation of amoxicillin.

Authors:  G N Rolinson
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

3.  Antimicrobial activity and human pharmacology of amoxicillin.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

4.  Levels of amoxicillin and ampicillin in human serum and interstitial fluid.

Authors:  J A Tan; T Bannister; J P Phair
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

5.  Amoxicillin in the treatment of infections of the lower respiratory tract.

Authors:  J R May; A Ingold
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

6.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

7.  Antibiotic antagonism in bacterial meningitis.

Authors:  A W Mathies; J M Leedom; D Ivler; P F Wehrle; B Portnoy
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

8.  Comparative effects of amoxycillin and ampicillin in the treatment of experimental mouse infections.

Authors:  K R Comber; C D Osborne; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

9.  Comparative effects of amoxycillin and ampicillin on the morphology of Escherichia coli in vivo and correlation with activity.

Authors:  K R Comber; R J Boon; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

  9 in total
  4 in total

Review 1.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

2.  Prevention of surgical site infection after open prosthetic inguinal hernia repair: efficacy of parenteral versus oral prophylaxis with amoxicillin-clavulanic acid in a randomized clinical trial.

Authors:  Mehmet A Kuzu; Selçuk Hazinedaroğlu; Sükrü Dolalan; Namik Ozkan; Samet Yalçin; A Bülent Erkek; Hatem Mahmoudi; Acar Tüzüner; Atilla H Elhan; Ercümet Kuterdem
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

Review 3.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

Review 4.  Amoxycillin injectable: a review of its antibacterial spectrum, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-09       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.